Clinical research on combination protocols, including the tattooing study mentioned earlier, supports this approach
As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity
Theoretical and route-specific risks FDA's 2024 review specifically flagged that no published human exposure data exists for the subcutaneous, transdermal, or intranasal routes that compounding pharmacies have offered
Because it is non-hormonal and naturally occurring, GHK-Cu avoids many of the strict regulatory barriers associated with drugs like minoxidil or finasteride
Vial headspace management affects oxidation rates at room temperature
Should researchers use retinol and peptides